Skip to main content
. 2016 Nov 18;11(11):e0166631. doi: 10.1371/journal.pone.0166631

Fig 2. Oxidative burst capacity of monocytes.

Fig 2

Panel A and B show the burst rate (B-R) in patients treated with triple therapy and IFN-free regimen, respectively. Panel C and D show the enzymatic activity per cell (median fluorescence intensity, B-MFI) in patients treated with triple therapy and IFN-free regimen, respectively. Data are analyzed at baseline (before starting antiviral therapy, n = 28), and at week 4 and 8 of therapy. * These comparisons were performed by Friedman tests.